Medical information Clinical review pending

Genetic Testing

FGFR1 Gene Craniosynostosis FGFR1 Related Genetic Test

Genetic test analyzing the FGFR1 gene to identify mutations associated with craniosynostosis, a condition involving premature skull suture closure. Useful for families with a history of the condition.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: A blood sample is typically required. Confirm specific sample type and volume with the laboratory before collection.
Results: Results are typically available within 3 to 4 weeks. Confirm the current turnaround time with the laboratory before booking.
Preparation: No special preparation is usually required for a blood draw. However, confirm with the laboratory for any specific instructions.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FGFR1 Gene Craniosynostosis FGFR1 Related Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals diagnosed with craniosynostosis.
✓Family history of craniosynostosis.
✓Patients presenting with symptoms suggestive of craniosynostosis (e.g., abnormal head shape).
✓Prenatal testing if a family history or prior child is affected.
✓Genetic counseling for families concerned about craniosynostosis risk.

In plain language

What this test helps you understand

This test helps identify specific mutations in the FGFR1 gene linked to craniosynostosis. It can aid in confirming a diagnosis, understanding the genetic basis of the condition in affected individuals and families, and potentially informing recurrence risk assessment for future pregnancies.

The FGFR1 Gene Craniosynostosis test is a specialized genetic analysis focused on the FGFR1 gene. Mutations in this gene are known to be associated with craniosynostosis, a condition where the fibrous joints between the bones of a baby's skull (sutures) close too early, potentially affecting brain growth and head shape. This test utilizes Next Generation Sequencing (NGS) technology to provide a detailed examination of the FGFR1 gene. It is particularly relevant for individuals or families with a known history of craniosynostosis, helping to understand the underlying genetic cause and inform clinical management or family planning decisions. Understanding the genetic basis can aid healthcare providers in making informed recommendations regarding potential interventions and monitoring.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is usually required for a blood draw. However, confirm with the laboratory for any specific instructions.

SampleA blood sample is typically required. Confirm specific sample type and volume with the laboratory before collection.

MethodologyNext Generation Sequencing (NGS) is used to analyze the FGFR1 gene for specific mutations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the FGFR1 gene. It does not detect mutations in other genes that can cause craniosynostosis. A negative result does not completely rule out a genetic cause, as other genetic factors or non-genetic causes may be involved. The test may not detect all possible types of mutations within the FGFR1 gene.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Craniosynostosis is a birth defect where one or more of the fibrous joints between the bones of a baby's skull close prematurely, affecting head shape and potentially brain growth.

Mutations in the FGFR1 gene are a known cause of certain types of craniosynostosis. Testing this gene can help identify the genetic basis for the condition in affected individuals and families.

This test is often recommended for individuals diagnosed with craniosynostosis, those with a family history of the condition, or parents concerned about the risk in future children.

A positive result indicates that a mutation associated with craniosynostosis was found in the FGFR1 gene. Discuss the implications of the specific finding with your doctor or a genetic counselor.

A negative result means no mutations associated with craniosynostosis were detected in the FGFR1 gene. Other genetic or non-genetic causes might be involved. Discuss this with your healthcare provider.

Results are typically provided through a detailed report sent to your referring physician. A genetic counseling session is often recommended to help understand the results and their implications.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp